Chief executive of the not-for-profit company will be Martin VanTrieste, the retired head of manufacturing quality at biotech drugmaker Amgen. ___.
News
- Hospital groups launch own company to make generic drugs
- Next Generation Sequencing Market 2026 Top Performing Key Players are Thermo Fisher ...
... Beijing Genomics Institute, Qiagen N.V., Pacific Biosciences of California, Inc., Perkinelmer, Inc., Agilent Technologies, ... San Antonio, TX,78202
- Marmosets serve as an effective model for non-motor symptoms of Parkinson's disease
San Antonio, Texas (September 5, 2018) - Small, New World monkeys called ... according to a new study by scientists at Texas Biomedical Research ...
- UTSA gets $1.5 million grant to support STEM students
SAN ANTONIO - The University of Texas at San Antonio has received a four-year, $1.5 million grant to improve student success and the diversity of ...
- Chemical weapons watchdog confirms UK nerve agent findings
... the same toxic chemical that was found in the biomedical and environmental samples relating to the poisoning" of former Russian spy Sergei Skripal ...